Skip to content

Evaluation of Tramadol/Paracetamol versus placebo in reducing pain of Electromyography study

Evaluation of Tramadol/paracetamol versus placebo as an analgesic in patients undergoing Electromyography study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012111011424N1
Enrollment
90
Registered
2013-04-24
Start date
2013-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain. pain in limb

Interventions

Intervention 1: two Tramadol/paracetamol(37.5/325 mg) tablets 2 hours before EMG study is done in every session. Intervention 2: two placebo tablets 2 hours before EMG study is done in every session.
Treatment - Drugs
Placebo
two Tramadol/paracetamol(37.5/325 mg) tablets 2 hours before EMG study is done in every session.
two placebo tablets 2 hours before EMG study is done in every session.

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria includes: normal subject aged between 18-50 years. Exclusion criteria includes: Epilepsy; Opioid hypersensitivity; Diabetes; Liver or Kidney dysfunction; Severe respiratory disease(asthma or Chronic Obstructive Pulmonary Disease); Opioid use or abuse; Selective Serotonin Reuptake Inhibitors or MAO inhibitor or analgesic use; Tricyclic Antidepressants or Neuroleptic use.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) score. Timepoint: after and 2 hours after EMG. Method of measurement: estimation of pain severity on 100 scale.

Secondary

MeasureTime frame
Side effects. Timepoint: after and 2 hours after drug consumption. Method of measurement: asking patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Tafakhori

Tehran University of Medical sciences

a_tafakhori@sian.tums.ac.ir+98 21 6119 2424

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026